A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2 - Related Studies

A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2

This study has been completed.

Study NCT00001812. Last updated on March 3, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Candidiasis, Oral
		Gastrointestinal Diseases
		Stomatitis

2	Additional conditions recognized in this trial
		Candidiasis

3	More general conditions related to this trial
		Digestive System Diseases
		Mouth Diseases
		Mycoses
		Stomatognathic Diseases

4	Interventions listed in this trial
		Nystatin

5	Additional drug interventions recognized in this trial
		Interleukin-2

6	More general drug interventions related to this trial
		Analgesics
		Analgesics, Non-Narcotic
		Anti-Bacterial Agents
		Anti-Infective Agents
		Antifungal Agents
		Antineoplastic Agents
		Central Nervous System Agents
		Ionophores
		Membrane Transport Modulators
		Molecular Mechanisms of Pharmacological Action
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Sensory System Agents
		Therapeutic Uses

7	Sponsors listed in this trial
		National Cancer Institute (NCI)